CAS 2241300-51-4

Formel: C16H14Cl2N8O

InChl: InChI=1S/C16H12N8O.2ClH/c1-8-19-10-3-2-9(6-11(10)20-8)24-13-4-5-18-7-12(13)21-16(24)14-15(17)23-25-22-14;;/h2-7H,1H3,(H2,17,23)(H,19,20);2*1H

InChI Key: LHUAALWRORLTCJ-UHFFFAOYSA-N

SMILES: CC1=NC2=C(N1)C=C(C=C2)N3C4=C(C=NC=C4)N=C3C5=NON=C5N.Cl.Cl

AS2863619

CAS: 2241300-51-4

AS2863619

Formel: C₁₆H₁₄Cl₂N₈O

Reinheit: 99.5%

Molekulargewicht: 405.24

Ref: 54-BUP04691

4-(1-(2-Methyl-1H-benzo[d]imidazol-6-yl)-1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine dihydrochloride

CAS: 2241300-51-4

Formel: C₁₆H₁₄Cl₂N₈O

Reinheit: 99%

Molekulargewicht: 405.2414

Ref: IN-DA01LIKP

AS2863619

CAS: 2241300-51-4

AS2863619 is an oral inhibitor of cyclin-dependent kinase(CDK8) and CDK19. Inhibition of CDK8/19 enhances STAT5 activation.Cost-effective and quality-assured.

Formel: C₁₆H₁₄Cl₂N₈O

Reinheit: 99.40% - >99.99%

Farbe und Form: White Solid

Molekulargewicht: 405.241

Ref: TM-T8378

AS2863619

CAS: 2241300-51-4

4-(1-(2-Methyl-1H-benzo[d]imidazol-6-yl)-1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine dihydrochloride

Formel: C₁₆H₁₄Cl₂N₈O

Reinheit: 99%

Molekulargewicht: 405.24

Ref: IN-DG01159300

AS 2863619

CAS: 2241300-51-4

Cyclin-dependent kinase 8 (CDK8) and CDK19 inhibitor

Formel: C₁₆H₁₄Cl₂N₈O

Reinheit: Min. 95%

Molekulargewicht: 405.24 g/mol

Ref: 3D-FA176468